Amyris Inc (fka AMRSQ)

[treppy]

Delaware

[First Crown Research]

what state is LAVVAN even registered in?

and im not alleging it's a fraud. that's a whole different legal standard. But do i think the equity is worth a 0? absolutely

[SubstitutedPinions]

Sorry, bro. Like, let me break it down for ya. They wanna be secret, so, like, um...don’t leave a trail. But the, like other side of the coin is like they’ve already done too much to not be real...’cause if it was some big frickin’ fraud, they just incriminated themselves.

Did that work? Make sense?

[First Crown Research]

what are you even talking about lolololol sounds like you might be using too many cannabinoid products

[SubstitutedPinions]

If the idea is to remain anonymous (and it is) then it’s hard not to leave a trail in building their web presence out more. It’s also, by the way, easy to prove deception with what they’ve already done if you say that’s their aim (it is not). Conclusion is it’s legit.

[beambe]

good Volume

[First Crown Research]

alright folks, usually i dont get into the battle this early but this co. is GARBAGE .... i mean the co. they've partnered with 'LAVVAN' ... .their website was registered TWO WEEKS AGO. DESPERATE BS .... they will not be able to make their maturities. You cant wait until you have 0 cash to file for bk and the cushion they have is no where close to what's needed. shorting as much as i can find

[Golden Cross]

RSI popped up from being oversold today! Looking good here...

[ClayTrader]

* * $AMRS Video Chart 03-27-2019 * *

Link to Video - click here to watch the technical chart video

[north40000]

Today is much better for us; and you too?

[whytestocks]

News: $AMRS Amyris to Present April 15 at Paradigm Capital Biosynthesis Conference - Exploring the Most Disruptive Technology in the Cannabis Industry

EMERYVILLE, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at th...

Read the whole news https://marketwirenews.com/news-releases/amyris-to-present-april-15-at-paradigm-capital-biosynthesis-conference-exploring-the-most-disruptive-technology-in-the-cannabis-industry-7899086.html

[LodieJ]

$AMRS played some real dirty pool with the way they threw out certain news articles. They ought to be sued over it. Shady shady. However....I expect the GOOD NEWS will start now at some point....

[ShadowSpy69]

glad I was migrating to ATRS since last fall. Still stings a tad but oh well. Who the hell knows with this pos now... cry wolf too many times and some day someone will call the bluff.

SMH

[mrinvestor08]

Glad I only put $5k in this...but I think we will rise up again. They have lots more in the tank.

Melo reminds me of eves lol

[ClayTrader]

* * $AMRS Video Chart 03-22-2019 * *

Link to Video - click here to watch the technical chart video

[cspratt15139]

He brings them short sellers for sure

[treppy]

Go home clay nobody likes you. Look at the discussion here it’s crickets. You scared everyone away lol. There is barn Fire and you are go to going to about stupid stairs. Use those stairs to get out of here

[ClayTrader]

* * $AMRS Video Chart 03-21-2019 * *

Link to Video - click here to watch the technical chart video

[BottomBounce]

$AMRS Amyris 4Q Loss/Shr $1.03 >AMRS

[ClayTrader]

* * $AMRS Video Chart 02-15-2019 * *

Link to Video - click here to watch the technical chart video

[ShadowSpy69]

LoL :p

[simmons420]

LoL ?? riiight, long here

[ShadowSpy69]

blah blah blah go away

[ClayTrader]

* * $AMRS Video Chart 02-12-2019 * *

Link to Video - click here to watch the technical chart video

[MDizzle]

Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications



Amyris, Inc. (Nasdaq:AMRS), and IDRI (Infectious Disease Research Institute), are pleased to announce IDRI’s receipt of a $4.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases (part of the U.S. National Institutes of Health) to discover sustainable alternatives to shark squalene to use as vaccine adjuvants (grant number: R01AI135673). Funding is provided by a special bioengineering research grant aimed at bringing engineering expertise to focus on a biomedical problem and ultimately develop a new solution.
Adjuvants are added to vaccines to enhance their effectiveness; the aim of the new project is to discover and evaluate novel, sustainable squalene-like compounds produced by bio- or chemical engineering for vaccine adjuvant applications.

IDRI has selected Amyris and the University of Nottingham, (UK) as partners because of their record of success in engineering pure molecules from sustainable sources at low cost. Instead of sourcing squalene from sharks, Amyris uses patented biotechnology to create squalene-like compounds using sugarcane syrup as the fermentation feedstock. Amyris has developed specific expertise as a clean manufacturer of sustainably sourced squalane.

“While one of our goals is to find a replacement for the pharmaceutical squalene derived from sharks, another key driver of this project is to understand how squalene formulations actually work as adjuvants,” said Christopher Fox, PhD, Vice President of Formulations at IDRI and principal investigator for the project. “By generating compounds with various structural alterations, we can study the structure-function relationship of squalene-like molecules and shine a light on their mechanisms of action.”

Fox added that key attributes of adjuvants in vaccines are the ability to improve an immune response and minimize the dose of vaccine necessary to confer immunity, which is particularly important where there is a disease outbreak that results in a vaccine shortage. “Development of this technology could enable formulations that effectively increase the number of vaccine doses available in the event of an influenza pandemic for example,” Fox said.

“We’re pleased to assist IDRI and to work with the University of Nottingham in this endeavor,” Amyris President, Research & Development Joel Cherry, Ph.D. said. “Today, we’re producing enormous amounts of squalane for customers around the world. This is a sustainably sourced version of squalane, with high purity and performance, and we’re looking forward to lending our assistance to apply what we know to benefit more people.”

[treppy]

[ClayTrader]

* * $AMRS Video Chart 02-11-2019 * *

Link to Video - click here to watch the technical chart video

[MDizzle]

Amyris Appoints Industry Veteran as President, Sweeteners and Ingredients, to Deliver Accelerated Growth



EMERYVILLE, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of Oreste Fieschi as President of Sweeteners & Ingredients, to lead the commercial growth of its sweetener business and the implementation of its strategy to build capability across the entire ingredients portfolio.

Oreste has a successful track record in commercial leadership roles in the food and beverage and natural ingredients sectors, along with deep expertise in global markets. This new position is driven by growth across Amyris's businesses and within the expanding market for the company's new, sugarcane-derived zero calorie sweetener.

Most recently, he led global sales and marketing as the Chief Commercial Officer for Naturex, a leader in natural ingredients recently bought by Givaudan. He has over 20 years' experience in senior commercial roles in diverse markets including chemicals, personal care, and food & beverage, including six years leading the sales growth strategy for Tate & Lyle Latin America. Prior to that, he held key commercial and business development roles with such companies as IFF, a leading developer and manufacturer of flavors and fragrances. Oreste holds a Master's degree in Business Administration from the Business School São Paulo, BSP (in partnership with Toronto University), and several other education certifications in finance and accounting, marketing, and chemical engineering.

"We welcome Oreste to Amyris at an inflection point when our businesses are experiencing solid, recurring revenue growth," said John Melo, Amyris President & CEO. "His proven experience as a successful leader in the markets we are growing, gives us a significant advantage toward maximizing the real opportunities ahead of us for revenue growth through key partnerships for our No Compromise(TM) ingredients."

Based in São Paulo and fluent in English, Portuguese and Spanish, Oreste will leverage his deep expertise globally to execute on Amyris's accelerated demand for the sweetener business.

[treppy]

Not being an Internet tough guy. You come around on big volume and your videos are basic.

[hiczer]

Technical view. Green to red move at 5.45. Possible First red day. Good sign of weakness this should drop more if it closes below 5.45. maybe another red day tomorrow for a good dip buy. Also the 255M deal isn't officially done yet.

[treppy]

https://www.bloomberg.com/news/articles/2019-02-05/pot-without-plants-is-goal-of-new-cannabis-fermentation-venture?utm_medium=social&cmpid=socialflow-twitter-business&utm_campaign=socialflow-organic&utm_source=twitter&utm_content=business

[north40000]

Good. Thanks for reply. We picked up another 1k this morning—$5.08.

[MDizzle]

I only blocked him for myself.

[north40000]

Put him on ignore for yourself. I hope you did not ban Clay from this message board itself. We have some 1000s of AMRS shares, and find his charts useful, but not controlling how we invest in AMRS. TIA

[Schabblestone]

Confirmed :)

[Gunga Galunga]

Agreed - waiting for the confirmation on reversal :)

[Schabblestone]

This will be pushing $7 in the next couple days

[treppy]

Thx!

[MDizzle]

I blocked that idiot.

[SubstitutedPinions]

Right. He wasn’t conjured, he’s like a bad penny.

[treppy]

He was going to appear regardless, always does with big movement

[TheFinalCD]

you talked him up....

lol

[SubstitutedPinions]

Lol

[ClayTrader]

* * $AMRS Video Chart 02-05-2019 * *

Link to Video - click here to watch the technical chart video

[treppy]

Where’s that dbag Clay?

[TheFinalCD]

https://www.nakedshortreport.com/company/AMRS

wow

[Trader2019]

Skyrocketing after hours, tomorrow up we go ! $$$$$$$ love it

[Trader2019]

Welcome aboard bro! Hell Yeah!
I think it should run till Thursday $$$$$$$$$ people are waking up on this one

[$$$-Play]

Volume speaks for itself. Gap up tomorrow.

[Trader2019]

Agreed! It should gap up at opening tomorrow, and hopefully we will find another winner as well !